Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 3.
doi: 10.1007/s12033-025-01468-8. Online ahead of print.

Extracellular Expression and Diagnostic Potential of Dengue Virus Type 3 E Protein Domain III Through Codon Optimization in Komagataella phaffii

Affiliations

Extracellular Expression and Diagnostic Potential of Dengue Virus Type 3 E Protein Domain III Through Codon Optimization in Komagataella phaffii

Camila Marques de Simone et al. Mol Biotechnol. .

Abstract

Dengue is a mosquito-borne viral disease caused by the dengue virus (DENV), which affects millions worldwide. The envelope (E) protein, particularly domain III (EDIII), plays a critical role in viral entry and is a major target for diagnostic and vaccine development. In this study, we aimed to express and purify EDIII from DENV-3 using Komagataella phaffii as an expression system. The recombinant gene was codonoptimized, cloned into the pPICZαA vector, and integrated into the K. phaffii genome. Protein expression was induced with methanol and purified using Ni2+-affinity chromatography, yielding 209-309 mg/L. SDS-PAGE and Western blot confirmed protein expression. The recombinant antigen was evaluated in an indirect ELISA with 92 serum samples, demonstrating an AUC of 0.94 (IgM) and 0.828 (IgG), with 92% specificity for IgM. These results suggest that K. phaffii is a suitable host for recombinant dengue antigen production, offering a scalable and cost-effective strategy for diagnostic applications.

Keywords: Bioprocess; Codon optimization; DENV; Dengue; Domain III (EDIII); Heterologous expression; Recombinant protein; Yeast.

PubMed Disclaimer

Similar articles

References

    1. Jamal, Z., Haider, S. A., Hakim, R., Humayun, F., Farooq, M. U., Ammar, M., Afrough, B., Inamdar, L., Salman, M., & Umair, M. (2024). Serotype and genomic diversity of dengue virus during the 2023 outbreak in Pakistan reveals the circulation of genotype III of DENV-1 and cosmopolitan genotype of DENV-2. Journal of Medical Virology, 96(6), e29727. https://doi.org/10.1002/jmv.29727 - DOI - PubMed
    1. da Silva, I. B. N., de Moraes Rodrigues, J., Batista, R. C. G., Dos Santos Gomes, V., de Souza Chacon, C., da Silva Almeida, M., de Araujo, T. S., Ortiz da Silva, B., Castiñeiras, T. M. P. P., Ferreira Junior, O. D. C., Carneiro, F. A., & Montero-Lomeli, M. (2024). Development and assessment of a multiepitope synthetic antigen for the diagnosis of Dengue virus infection. Brazilian Journal of Infectious Diseases, 28(3), 103746. https://doi.org/10.1016/j.bjid.2024.103746 - DOI
    1. Munt, J. E., Henein, S., Adams, C., Young, E., Hou, Y. J., Conrad, H., Zhu, D., Dong, S., Kose, N., Yount, B., Meganck, R. M., Tse, L. P. V., Kuan, G., Balmaseda, A., Ricciardi, M. J., Watkins, D. I., Crowe, J. E., Harris, E., De Silva, A. M., & Baric, R. S. (2023). Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination. Cell Host and Microbe, 31(11), 1850.e5-1865.e5. https://doi.org/10.1016/j.chom.2023.10.004 - DOI
    1. Zhu, D. R., Rajesh, A. J., Meganck, R. M., Young, E. F., Munt, J. E., Tse, V. L., Yount, B., Conrad, H., White, L., Henein, S., De Silva, A. M., & Baric, R. S. (2023). Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2. MBio, 14(5), e0081823. https://doi.org/10.1128/mbio.00818-23 - DOI - PubMed
    1. Li, Z., Liu, H.-Y., He, Z., Chakravarty, A., Golden, R. P., Jiang, Z., You, I., Yue, H., Donovan, K. A., Du, G., Che, J., Tse, J., Che, I., Lu, W., Fischer, E. S., Zhang, T., Gray, N. S., & Yang, P. L. (2024). Discovery of potent degraders of the Dengue virus envelope protein. bioRxiv, 11(40), e2405829. https://doi.org/10.1101/2024.06.01.596987 - DOI

LinkOut - more resources